NEURONES (NE9.SG)
NEURONES (NE9.SG) operates in Diversified Metals & Mining.
NEURONES (NE9.SG) (NE9) - Net Assets
Latest net assets as of December 2023: €407.91 Million EUR
Based on the latest financial reports, NEURONES (NE9.SG) (NE9) has net assets worth €407.91 Million EUR as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€674.25 Million) and total liabilities (€266.34 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €407.91 Million |
| % of Total Assets | 60.5% |
| Annual Growth Rate | 8.82% |
| 5-Year Change | 24.62% |
| 10-Year Change | 107.19% |
| Growth Volatility | 3.89 |
NEURONES (NE9.SG) - Net Assets Trend (2013–2023)
This chart illustrates how NEURONES (NE9.SG)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NEURONES (NE9.SG) (2013–2023)
The table below shows the annual net assets of NEURONES (NE9.SG) from 2013 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €407.91 Million | +8.46% |
| 2022-12-31 | €376.08 Million | +6.56% |
| 2021-12-31 | €352.92 Million | -1.70% |
| 2020-12-31 | €359.02 Million | +9.69% |
| 2019-12-31 | €327.32 Million | +10.63% |
| 2018-12-31 | €295.88 Million | +10.38% |
| 2017-12-31 | €268.05 Million | +12.41% |
| 2016-12-31 | €238.46 Million | +10.52% |
| 2015-12-31 | €215.75 Million | +9.59% |
| 2014-12-31 | €196.88 Million | +12.37% |
| 2013-12-31 | €175.21 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to NEURONES (NE9.SG)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €354.39 Million | 100.00% |
| Total Equity | €354.39 Million | 100.00% |
NEURONES (NE9.SG) Competitors by Market Cap
The table below lists competitors of NEURONES (NE9.SG) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GS Holdings Corp. Pfd. Series 1
KQ:078935
|
$338.81K |
|
OSAKA GAS - Dusseldorf Stock Exchang
DU:OSA
|
$338.86K |
|
MUEHLBAUER HOLDING - Dusseldorf Stock Exchang
DU:MUB
|
$338.92K |
|
Epsilon Healthcare Limited
PINK:HDRPF
|
$338.96K |
|
Norvista Capital Corporation
PINK:XTERF
|
$338.66K |
|
ALL FOR ONE STEEB (A1OS.SG)
STU:A1OS
|
$338.33K |
|
CSTAF
PINK:CSTAF
|
$338.32K |
|
Hire Technologies Inc
OTCQB:HIRRF
|
$338.31K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NEURONES (NE9.SG)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 331,078,000 to 354,389,000, a change of 23,311,000 (7.0%).
- Net income of 49,410,000 contributed positively to equity growth.
- Dividend payments of 26,647,000 reduced retained earnings.
- New share issuances of 57,000 increased equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €49.41 Million | +13.94% |
| Dividends Paid | €26.65 Million | -7.52% |
| Share Issuances | €57.00K | +0.02% |
| Other Changes | €491.00K | +0.14% |
| Total Change | €- | 7.04% |
Book Value vs Market Value Analysis
This analysis compares NEURONES (NE9.SG)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.44x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.56x to 2.44x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €10.02 | €35.65 | x |
| 2018-12-31 | €10.99 | €35.65 | x |
| 2019-12-31 | €12.24 | €35.65 | x |
| 2020-12-31 | €13.33 | €35.65 | x |
| 2021-12-31 | €12.86 | €35.65 | x |
| 2022-12-31 | €13.67 | €35.65 | x |
| 2023-12-31 | €14.60 | €35.65 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NEURONES (NE9.SG) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.94%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.67%
- • Asset Turnover: 1.10x
- • Equity Multiplier: 1.90x
- Recent ROE (13.94%) is above the historical average (11.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 11.48% | 5.41% | 1.23x | 1.72x | €2.39 Million |
| 2014 | 11.36% | 5.77% | 1.17x | 1.69x | €2.45 Million |
| 2015 | 10.76% | 5.35% | 1.14x | 1.77x | €1.52 Million |
| 2016 | 11.61% | 5.64% | 1.16x | 1.78x | €3.50 Million |
| 2017 | 11.24% | 5.63% | 1.18x | 1.69x | €3.01 Million |
| 2018 | 9.73% | 5.30% | 1.09x | 1.68x | €-724.10K |
| 2019 | 10.36% | 6.04% | 1.00x | 1.72x | €1.08 Million |
| 2020 | 9.58% | 5.89% | 0.95x | 1.70x | €-1.34 Million |
| 2021 | 12.10% | 6.50% | 1.02x | 1.82x | €6.55 Million |
| 2022 | 13.36% | 6.65% | 1.08x | 1.86x | €11.14 Million |
| 2023 | 13.94% | 6.67% | 1.10x | 1.90x | €13.97 Million |
Industry Comparison
This section compares NEURONES (NE9.SG)'s net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $114,212,818,724
- Average return on equity (ROE) among peers: -9.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NEURONES (NE9.SG) (NE9) | €407.91 Million | 11.48% | 0.65x | $338.68K |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $989.01K |
| Tokyu Corporation (01T) | $779.37 Billion | 3.34% | 2.35x | $99.73K |
| GUANGZHOU AUTO -H- (02G) | $122.28 Billion | 6.59% | 0.55x | $4.05K |
| MOSAIC (02M) | $10.60 Billion | 4.43% | 0.90x | $280.83K |
| MOSAIC (02M.SG) (02M) | $9.56 Billion | 10.46% | 0.82x | $247.21K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $16.67 Million | -126.83% | 4.46x | $1.55 Million |
| KRAKATAU STEEL -B- (07K) | $552.59 Million | 3.52% | 4.72x | $166.99 |
| CN MODERN DAIRY (07M) | $7.12 Billion | -10.42% | 1.50x | $1.68K |
| TOURMALINE OIL (08T) | $7.22 Billion | 4.81% | 0.41x | $381.02K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $325.03 |